We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The documentation accompanying an application for a marketing authorisation pursuant to Schedule 1 of the Veterinary Medicines Regulations shall be presented in accordance with the requirements set out in this Annex.
This Section lays down specific requirements for identified veterinary medicinal products related to the nature of the active substances contained therein.
Details of the VMD Corporate Priorities for 2025 - 2026.
All national applications will be processed on one of six timetables that vary in length depending on the complexity and nature of the application under assessment.
Industry webinars on the main changes affecting veterinary surgeons, wholesalers and retailers supplying veterinary medicines in Northern Ireland.
The VMR sets out the statutory fees associated with various regulatory services provided by the VMD. The statutory fees and fee structure are implemented from 17 May 2024.
The following detailed requirements shall apply to veterinary medicinal products other than biological veterinary medicinal products, except where otherwise set out in Section IV.
Guidance for vets, farmers and animal keepers on what the mg/PCU means and how it is calculated.
Summary of product characteristics for BLUEVAC-3 BTV-3 vaccine in the UK
First published during the 2024 to 2026 Starmer Labour government
Effective from 17 May 2024 Definitive fees charged for applications under Schedule 7 of Veterinary Medicines Regulations 2013 (as amended) as they apply to GB.
Actions to be taken by Marketing Authorisation Holders in order to supply veterinary medicines to Northern Ireland from 1 January 2026.
Details of certificates issued under the Special Import System for the top ten veterinary medicines that were imported 1 October to 31 December 2024.
How to make sure an application relating to an authorisation for a veterinary medicine is complete and will pass validation.
Sourcing medicines via online pharmacies, impact on prices and trading with the EU, such as food products from 1 January 2026.
Requirements for stock inventories which must be performed regularly.
Summary of product characteristics for Bultavo-3 BTV-3 vaccine in the UK
Privacy notice regarding personal data processed by the VMD.
Guidance on Pharmacovigilance reporting.
Explainer for businesses and persons regulated by the Veterinary Medicines Regulations 2013, as amended, on the transitional provisions included in the amending legislation: the Veterinary Medicines (Amendment etc.) Regulati…
Information for beekeepers about inspections the Animal and Plant Health Agency carries out on colonies, veterinary medicine records and honey samples.
Do not include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).